1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc.
XNAS: AMGN

Amgen Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Read More
366.29 -5.29 (-1.42%)
35.78% Gain from 52W Low
2.9M
XNAS Volume

XNAS 17 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
40.5 / 100
Momentum Score
Technically Neutral
57.2 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
357
1Yr Price target downside is -3%
29 analysts

11

S

7

W

5

O

0

T

SWOT Analysis

Amgen Live Price Chart

Switch to TradingView
Switch to

Amgen Live Price Chart

Custom


Loading Fundamental data..


Loading data..
×